Résumé
Les liens entre obésité et cancer du sein pourraient résulter de l’action d’adipokines produites par les cellules adipeuses. Parmi ces adipokines, la leptine semble jouer un rôle important. La présence de ses récepteurs sur les cellules de cancers du sein montre qu’elle peut agir directement sur ces cellules: elle est de fait capable de stimuler leur prolifération. Les voies d’action empruntées sont endocrine, paracrine et autocrine. De plus, la leptine serait capable de s’opposer aux traitements anti-estrogéniques. Ces observations suggèrent que le blocage de la leptine aurait un intérêt thérapeutique dans les cancers du sein.
Abstract
Links between obesity and breast cancer could result from the action of adipokines produced by adipocytes. Among these adipokines, leptin appears to have an important role. The presence of its receptors on breast cancer cells shows that it can act directly on these cells: it is able to stimulate their proliferation. There are three distinct modes of action through endocrine-, paracrine-, and autocrine-mediated pathways. Moreover, leptin would appear to be able to counteract anti-estrogenic treatments. These observations suggest that it could be of therapeutic interest to target leptin in breast cancer.
Article PDF
Avoid common mistakes on your manuscript.
Références
Key TJ, Appleby PN, Reeves GK, et al. (2003) Endogenous Hormones Breast Cancer Collaborative Group. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95: 1218–1226
Van den Brandt PA, Spiegelman D, Yaun SS, et al. (2000) Pooled analysis of prospective cohort studies on height, weight and breast cancer risk. Am J Epidemiol 152: 514–527
Porter GA, Inglis KM, Wood LA, Veugelers PJ (2006) Effect of obesity on presentation of breast cancer. Ann Surg Oncol 13: 327–332
Zhang Y, Proence R, Maffei M, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425–432
Rose DP, Gilhooly EM, Nixon DW (2002) Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). Int J Oncol 21: 1285–1292
Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, et al. (2002) Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 293: 622–628
Hu X, Juneja SC, Maihle NJ, Cleary MP (2002) Leptin: a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94: 1704–1711
Laud K, Gourdou I, Pessemesse L, et al. (2002) Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 188: 219–226
Garofalo C, Surmacz E (2006) Leptin and cancer. J Cell Physiol 207(1): 12–22
Frankenberry KA, Skinner H, Somasundar P, et al. (2006) Leptin receptor expression and cell signaling in breast cancer. Int J Oncol 28: 985–993
Chen C, Chang YC, Liu CL, et al. (2006) Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast cancer Res Treat 98: 121–132
Catalano S, Mauro L, Marsico S, et al. (2004) Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J Biol Chem 279: 19908–19915
Catalano S, Marsico S, Giordano, et al. (2003) Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem 278: 28668–28676
Garofalo C, Sisci D, Surmacz E (2004) Leptin interferes with the effects of the anti-estrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res 10: 6466–6475
O’Brien SN, Welter BH, Price TM (1999) Presence of leptin in breast cell lines and breast tumors. Biochem Biophys Res Commun 259: 695–698
Cleary MP, Phillips FC, Getsin SC, et al. (2003) Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat 77: 205–215
Cleary MP, Juneja SC, Phillips FC, et al. (2004) Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors. Exp Biol Med 229: 182–193
Goodwin PJ, Ennis M, Fantus IG, et al. (2005) Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 23: 6037–6042
Tessitore L, Vizio B, Jenkins O, et al. (2000) Leptin expression in colorectal and breast cancer patients. Int J Mol Med 5: 421–426
Han C, Zhang HT, Du L, et al. (2005) Serum levels of leptin, insulin, and lipids in relation to breast cancer in china. Endocrine 26: 19–24
Chen DC, Chung YF, Yeh YT, et al. (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237: 109–114
Falk RT, Brinton LA, Madigan MP, et al. (2006) Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women. Breast Cancer Res Treat 98: 157–165
Petridou E, Papadiamantis Y, Markopoulos C, et al. (2000) Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11: 383–388
Ozet A, Arpaci F, Yilmaz MI, et al. (2001) Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol 31: 424–427
Coskun U, Günel N, Toruner FB, et al. (2003) Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Neoplasma 50: 41–46
Sauter ER, Garofalo C, Hewett J, et al. (2004) Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer. Horm Metab Res 36: 336–340
Miyoshi Y, Funahashi T, Tanaka S, et al. (2006) High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 118: 1414–1419
Woo HY, Park H, Ki CS, et al. (2006) Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Lett 237: 137–142
Stattin P, Söderberg S, Biessy C, et al. (2004) Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat 86: 191–196
Cento RM, Proto C, Spada RS, et al. (1999) Leptin levels in menopause: effect of estrogen replacement therapy. Horm Res 52: 269–273
Hayase H, Nomura S, Abe T, Izawa T (2002) Relation between fat distributions and several plasma adipocytokines after exercise training in premenopausal and post-menopausal women. J Physiol Anthropol Appl Human Sci 21: 105–113
Caprio M, Fabbrini E, Isidori AM, et al. (2001) Leptin in reproduction. Trends Endocrinol Metab 12: 65–72
Messinis IE, Papageorgiou I, Milingos S, et al. (2001) Estradiol plus progesterone treatment increases serum leptin concentrations in normal women. Hum Reprod 16: 1827–1832
Tartaglia LA, Dembski M, Weng X, et al. (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263–1271
Barr VA, Lane K, Taylor SI (1999) Subcellular localization and internalization of the four human leptin receptor isoformes. J Biol Chem 274: 21416–21424
Tartaglia LA (1997) The leptin receptor. J Biol Chem 272: 6093–6096
Winick JD, Stoffel M, Friedman JM (1996) Identification of microsatellite markers linked to the human leptin receptor gene on chromosome 1. Genomics 36: 221–222
Bjorbaek C, Uotani S, da Silva B, Flier JS (1997) Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272: 32686–32695
Yamashita T, Murakami T, Otani S, et al. (1998) Leptin receptor signal transduction: OBRa and OBRb of fa type. Biochem Biophys Res Commun 246: 752–759
Sinha MK, Poentanova I, Ohannesian JP, et al. (1996) Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 98: 1277–1282
Brabant G, Nave H, Mayr B, et al. (2002) Secretion of free and protein-bound leptin from subcutaneous adipose tissue of lean and obese women. J Clin Endocrinol Metab 87: 3966–3970
Maamra M, Bidlingmaier M, Postel-Vinay MC, et al. (2001) Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology 142: 4389–4393
Ge H, Huang L, Pourbahrami T, Li C (2002) Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo. J Biol Chem 277: 45898–45903
Révillion F, Charlier M, Lhotellier V, et al. (2006) Messenger RNA expression of leptin and leptin receptors and their prognostic value in human primary breast cancer. Clin Cancer Res 12: 2088–2094
Ishikawa M, Kitayama J, Nagawa H (2004) Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10: 4325–4331
Tessitore L, Vizio B, Pesola D, et al. (2004) Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol 24: 1529–1535
Révillion F, Bonneterre J, Peyrat JP (1998) ERBB2 oncogene in human breast cancer and its clinical significance. Eur J Cancer 34: 791–808
Pawlowski V, Révillion F, Hebbar M, et al. (2000) Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 6: 4217–4225
Eisenberg A, Biener E, Charlier M, et al. (2004) Transactivation of erbB2 by short and long isoforms of leptin receptors. FEBS Lett 565: 139–142
Soma D, Kitayama J, Yamashita H, et al. (2007) Leptin augments proliferation of breast cancer cells via transactivation of HER2. J Surg Res. [Epub ahead of print]
Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P (2002) A polymorphism in the leptin promoter region (−2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 34: 355–359
Mammès O, Betoulle D, Aubert R, et al. (1998) Novel polymorphisms in the 5′ region of the LEP gene: association with leptin levels and response to low calorie diet in human obesity. Diabetes 47: 487–489
Li WD, Reed DR, Lee JH, et al. (1999) Sequence variants in the 5′ flanking region of the leptin gene are associated with obesity in women. Ann Hum Genet 63: 227–234
Wang TN, Huang TN, Chang WT, et al. (2006) G-2548A polymorphism of the leptin gene is correlated with extreme obesity in Taiwanese aborigines. Obesity 14: 183–187
Mammès O, Aubert R, Betoulle D, et al. (2001) LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women. Eur J Clin Invest 31: 398–404
Yiannakouris N, Yannakoulia M, Melistas L, et al. (2001) The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 86: 4434–4439
Duarte SF, Francischetti EA, Genelhu-Abreu V, et al. (2006) p.Q223R leptin receptor polymorphism associated with obesity in Brazilian multi-ethnic subjects. Am J Hum Biol 18: 448–453
Snoussi K, Strosberg AD, Bouaouina N, et al. (2006) Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 6: 38
Liu CL, Chang YC, Cheng SP, et al. (2007) The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology 72: 75–81
Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14(2): 189–206
Surmacz E (2007) Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res 9: 301
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peyrat, J.P., Révillion, F., Grosjean, J. et al. La leptine: un lien entre obésité et cancer du sein. Obes 3, 66–71 (2008). https://doi.org/10.1007/s11690-008-0120-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11690-008-0120-x